Reynders McVeigh Capital Management, LLC
Position in BMY — Bristol Myers Squibb Co
CIK 1455969
BOSTON, MA
Position in BMY
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$1,085,877
+$126,177 QoQ
Shares Held
17,904
+0.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Reynders McVeigh Capital Management, LLC holds $48,961,420 across 8 Drug Manufacturers - General names. BMY ranks #7 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
76,014 | $18,580,862 | |
| 2 | NVS |
Novartis AG
|
73,392 | $11,210,628 | |
| 3 | ABBV |
AbbVie Inc.
|
29,052 | $6,318,519 | |
| 4 | LLY |
ELI LILLY & Co
|
5,986 | $5,505,743 | |
| 5 | AMGN |
Amgen Inc
|
9,182 | $3,230,686 | |
| 6 | MRK |
Merck & Co., Inc.
|
22,387 | $2,692,932 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
17,904 | $1,085,877 | |
| 8 | PFE |
Pfizer Inc
|
11,972 | $336,173 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,085,877 | 17,904 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $959,700 | 17,792 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $761,829 | 16,892 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $813,454 | 17,573 | Shares | Sole | 2025-09-04 | |
| 2025-03-31 | $1,067,325 | 17,500 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,010,953 | 17,874 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,036,041 | 20,024 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $833,424 | 20,068 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,076,194 | 19,845 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $1,184,953 | 23,094 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $1,458,719 | 25,133 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,618,830 | 25,314 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,712,927 | 24,714 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $1,834,005 | 25,490 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,812,795 | 25,500 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $2,068,220 | 26,860 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $1,644,197 | 22,514 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,410,606 | 22,624 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,378,483 | 23,297 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,796,255 | 26,882 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,806,275 | 28,612 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $1,885,153 | 30,391 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,999,578 | 33,166 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $2,161,311 | 36,757 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,623,260 | 29,122 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||